who medicines strategy - libdoc.who.int - World Health Organization

who medicines strategy - libdoc.who.int - World Health Organization who medicines strategy - libdoc.who.int - World Health Organization

steinergraphics.com
from steinergraphics.com More from this publisher
10.07.2015 Views

WHO MEDICINES STRATEGY 2004-2007 | 118EO 7.3Independent and reliablemedicines information identified,disseminated, and promotedRationaleProgressReliable, objective, and evidence-basedThe major advance in this area has been theinformation is the foundation of rationalproduction of the WHO Model Formulary andmedicines use. With the development ofthe WHO Medicines Library (see also EO 7.2). Inspecialized networks and websites, access to such addition, a manual on the production of Nationalinformation is readily available in most parts of or Institutional Formularies based on the WHOthe world where there is access to the Internet. Model Formulary will be released in 2004.However, this still leaves many countries without This manual will be issued as a CD-ROM, alsoaccess to independent and reliable medicinescontaining the WHO Model Formulary.information. In a global survey carried out in1999, only 50% of 138 reporting countries hadDrug Information Centres. The regional rangewas 40%-89%. The lack of independent andreliable medicines information in many countriesis compounded by the pharmaceutical industry’sinvestment in marketing activities, includingdirect-to-consumer advertising. In the USA, forexample, the pharmaceutical industry spentabout US$ 15 billion on promotional activities in2000. 61

COMPONENTS OF THE STRATEGY | 119Challenges remainingInformation available to professionals andconsumers is frequently provided by themanufacturers or suppliers of medicines, bothof which have a commercial interest, ratherthan from independent sources with a consumerinterest. The imbalance in funding for suchactivities means that it is difficult for prescribers toobtain comparative unbiased information.Meeting the challenges 2004-2007Over the next four years WHO will:> provide technical support to strengthennational capacity to develop and disseminatemedicines information.> support national efforts to produce nationalor institutional formularies and national druginformation bulletins.> work with the International Society of DrugBulletins to produce a manual for use atnational level in the production of DrugInformation Bulletins.OUTCOME INDICATORS1999 2003 2007No. of countries with a national medicines informationcentre able to provide independent information onmedicines to prescribers and/or dispensersNo. of countries with a medicines information centre /service accessible to consumers#REPORTING % TARGET#REPORTING % TARGET62/123 50% 59% 53/129 41% 50%na na na 45/127 35% 40%

WHO MEDICINES STRATEGY 2004-2007 | 118EO 7.3Independent and reliable<strong>medicines</strong> information identified,disseminated, and promotedRationaleProgressReliable, objective, and evidence-basedThe major advance in this area has been theinformation is the foundation of rationalproduction of the WHO Model Formulary and<strong>medicines</strong> use. With the development ofthe WHO Medicines Library (see also EO 7.2). Inspecialized networks and websites, access to such addition, a manual on the production of Nationalinformation is readily available in most parts of or Institutional Formularies based on the WHOthe world where there is access to the Internet. Model Formulary will be released in 2004.However, this still leaves many countries without This manual will be issued as a CD-ROM, alsoaccess to independent and reliable <strong>medicines</strong>containing the WHO Model Formulary.information. In a global survey carried out in1999, only 50% of 138 reporting countries hadDrug Information Centres. The regional rangewas 40%-89%. The lack of independent andreliable <strong>medicines</strong> information in many countriesis compounded by the pharmaceutical industry’sinvestment in marketing activities, includingdirect-to-consumer advertising. In the USA, forexample, the pharmaceutical industry spentabout US$ 15 billion on promotional activities in2000. 61

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!